DANVERS, Mass.–(BUSINESS WIRE)–CCC, a leader in promoting copyright, accelerating knowledge and driving innovation, has contracted with the Chinese Medical Association Publishing House (CMAPH) to offer document delivery and licensing solutions for all CMAPH journals. CMA titles will now be included in the Republishing License Service on CCC Marketplace and Document Delivery with RightFind. CMAPH is the leading publisher of medical journals in China, including the prestigious Chinese medical journal and National Medical Journal of China.
This agreement with CCC allows for wider distribution and global access to Chinese medical articles. International medical researchers now have seamless access to use and replicate Chinese research in pursuit of medical innovations.
CCC Marketplace is the one-stop-shop for copyright clearances and article reprints and serves as an online hub for licensing rights, including republication rights. CCC Marketplace offers an advanced workflow and simple shopping experience allowing users to easily search, find and obtain permissions to reuse content from thousands of publishers and rights holders around the world and buy reprints of articles.
RightFind is CCC’s award-winning search solution used by hundreds of global R&D teams and other enterprise content users, from the smallest emerging life science companies to the largest global R&D organizations. RightFind provides centralized, copyright-compliant, transparent access to high-value subscription and license content and offers on-demand document delivery through intuitive software and services. It consists of a set of comprehensive application modules that seamlessly integrate with CCC’s annual copyright licenses.
“For medical researchers around the world, having access to the latest research, regardless of geography, is critical,” said Michael Healy, Executive Director, International Relations, CCC. “We are delighted to include the extensive collection of CMA titles in our CCC Marketplace and RightFind services.
“All mankind is a community with a shared future, and the results of scientific research are the common good of all mankind,” said Xibin Shen, Director of Digital Publishing Department, CMA Publishing House. “We are happy to show the world the latest achievements of Chinese biomedical researchers via the CCC platform and to share our wisdom with life science researchers around the world. I am also very happy to recommend CCC to my colleagues at Chinese STM journals.
A pioneer in voluntary collective licensing, CCC (Copyright Clearance Center) helps organizations integrate, access and share information through licensing, content, software and professional services. Using their expertise in copyright and information management, CCC and its subsidiary RightsDirect work with stakeholders to design and deliver innovative information solutions that fuel decision-making by helping people integrate and browse data sources and content assets.
The Chinese Medical Association (CMA) Publishing House is a medical publishing house affiliated with the society, which aims to publish national journals of general medicine and various specialties. Until July 2022, the publishing house has published 154 journals, the largest series of medical journals in China. Of the 154 journals, 22 are published in English and 132 are published in Chinese with an English abstract.